Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E PROTEIN KINASE INHIBITORS
L01EX Other protein kinase inhibitors
L01EX25 Umbralisib
D11323 Umbralisib tosylate (USAN) <US>
USP drug classification [BR:br08302]
Antineoplastics
Molecular Target Inhibitors
Umbralisib
D11323 Umbralisib tosylate (USAN)
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
CK1 group
CSNK1E
D11323 Umbralisib tosylate (USAN) <US>
Enzymes
Transferases (EC2)
Phosphotransferase
PIK3CD
D11323 Umbralisib tosylate (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11323
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11323